Ristegra Dispersible Tablets 10 mg Dispersible Tablet
PDF Leaflet Revision Date: 21 June 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in combination with other antiretroviral medicines.
Dosage (summary)
Adults: 30 mg once daily or twice daily if resistant. Children: Dosing based on weight.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in first trimester; use with caution in pregnancy and breastfeeding.
Key Drug Interactions
- Etravirine, Efavirenz, Nevirapine, Rifampicin, Carbamazepine
Contraindications
- Hypersensitivity to dolutegravir
- Severe hepatic impairment
- Co-administration with dofetilide and pilsicainide
Common side effects
- Insomnia
- Headache
- Nausea
- Rash
- Fatigue
Counselling Points
- Take with or without food.
- Monitor for signs of hypersensitivity.
- Use effective contraception in women of childbearing potential.
Serious warnings
- Hypersensitivity reactions
- Immune Reconstitution Syndrome
- Osteonecrosis
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
